Your browser doesn't support javascript.
loading
A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2'O-Methylated Self RNA.
Schuberth-Wagner, Christine; Ludwig, Janos; Bruder, Ann Kristin; Herzner, Anna-Maria; Zillinger, Thomas; Goldeck, Marion; Schmidt, Tobias; Schmid-Burgk, Jonathan L; Kerber, Romy; Wolter, Steven; Stümpel, Jan-Philip; Roth, Andreas; Bartok, Eva; Drosten, Christian; Coch, Christoph; Hornung, Veit; Barchet, Winfried; Kümmerer, Beate M; Hartmann, Gunther; Schlee, Martin.
Afiliação
  • Schuberth-Wagner C; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Ludwig J; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Bruder AK; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Herzner AM; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Zillinger T; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany; German Center for Infection Research Cologne-Bonn.
  • Goldeck M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Schmidt T; Institute of Molecular Medicine, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Schmid-Burgk JL; Institute of Molecular Medicine, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Kerber R; Department of Virology, Bernhard-Nocht-Institute for Tropical Medicine, 20259 Hamburg, Germany.
  • Wolter S; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Stümpel JP; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Roth A; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Bartok E; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Drosten C; Institute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany.
  • Coch C; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Hornung V; Institute of Molecular Medicine, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Barchet W; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany; German Center for Infection Research Cologne-Bonn.
  • Kümmerer BM; Institute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany.
  • Hartmann G; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany.
  • Schlee M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, 53105 Bonn, Germany. Electronic address: martin.schlee@uni-bonn.de.
Immunity ; 43(1): 41-51, 2015 Jul 21.
Article em En | MEDLINE | ID: mdl-26187414
ABSTRACT
The cytosolic helicase retinoic acid-inducible gene-I (RIG-I) initiates immune responses to most RNA viruses by detecting viral 5'-triphosphorylated RNA (pppRNA). Although endogenous mRNA is also 5'-triphosphorylated, backbone modifications and the 5'-ppp-linked methylguanosine ((m7)G) cap prevent immunorecognition. Here we show that the methylation status of endogenous capped mRNA at the 5'-terminal nucleotide (N1) was crucial to prevent RIG-I activation. Moreover, we identified a single conserved amino acid (H830) in the RIG-I RNA binding pocket as the mediator of steric exclusion of N1-2'O-methylated RNA. H830A alteration (RIG-I(H830A)) restored binding of N1-2'O-methylated pppRNA. Consequently, endogenous mRNA activated the RIG-I(H830A) mutant but not wild-type RIG-I. Similarly, knockdown of the endogenous N1-2'O-methyltransferase led to considerable RIG-I stimulation in the absence of exogenous stimuli. Studies involving yellow-fever-virus-encoded 2'O-methyltransferase and RIG-I(H830A) revealed that viruses exploit this mechanism to escape RIG-I. Our data reveal a new role for cap N1-2'O-methylation in RIG-I tolerance of self-RNA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Febre Amarela / RNA / Processamento Pós-Transcricional do RNA / RNA Helicases DEAD-box / Tolerância Imunológica Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Febre Amarela / RNA / Processamento Pós-Transcricional do RNA / RNA Helicases DEAD-box / Tolerância Imunológica Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article